Mature Brands and Loss Of Exclusivity Optimisation Strategy

Pharmawise can support you in developing, broad-ranging strategic toolkit to cushion the patent loss impact as we consider all the options and strategies Generic companies will employ to penetrate your market.

  • Poor LOE management results in significant loss of revenue in first year.
  • Our solutions are embedded in deep and rigorous generic/biosimilar market knowledge, combining focused primary research, and competitive intelligence and revenue modeling to support strategic decision making.
    • Patent loss preparedness audit
    • Generic/biosimilar industry insights
    • Patent loss management strategy evaluation and development
    • Strategic planning workshops
    • Life cycle management

Pharmawise aims support you in the following activities to:

  • Maximise your pre-patent revenue and protect the exclusivity time window where possible
  • Optimise your overall commercial position during patent loss events, seeking to minimise revenue and profit loss following patent expiration
  • Identify initiatives to extend the brand franchise, in addition to those which afford protection
  • Provide a focal point for patent-loss strategic planning across the whole organisation which is independent, cost-efficient and rigorous enough to satisfy board-level scrutiny or challenge
  • Identify key risks from the implementation of new strategic initiatives and the likely competitor response, through to cross–border implications of proposed national strategies and tactics